Oct 2022 $15 M No. 7 $10 to $50 million 32
Surefire Medical, Inc.: Raise no. 7, Oct 2022 × Investors in this round 32 investors had bought by the notice of Nov 10, 2022: 32 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $42 M offered; $27 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Colorado People named in the notice Mary T. Szela · Executive Officer, Director Sean Murphy · Executive Officer, Director Anil Singhal · Director Diane Parks · Director Gene McGrevin · Director John L. Tullis · Director Kerry Hicks · Director Mats L. Wahlstrom · Director Simone Song · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mary Szela, President. Source: SEC Form D, newest notice filed Nov 10, 2022. Read the notice at the SEC .
equity, options SEC Sep 2021 $24 M No. 6 $10 to $50 million 4
Surefire Medical, Inc.: Raise no. 6, Sep 2021 × Investors in this round 4 investors had bought by the notice of Nov 10, 2022: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $24 M of $24 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Colorado People named in the notice Mary T. Szela · Executive Officer, Director Raj L. Mistry · Executive Officer Sean Murphy · Executive Officer, Director Anil Singhal · Director Diane Parks · Director Gene McGrevin · Director John L. Tullis · Director Kerry Hicks · Director Mats L. Wahlstrom · Director Simone Song · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mary Szela, President. Source: SEC Form D, newest notice filed Nov 10, 2022. Read the notice at the SEC .
equity SEC Mar 2021 $81 M No. 5 $50 to $250 million 57
Surefire Medical, Inc.: Raise no. 5, Mar 2021 × Investors in this round 57 investors had bought by the notice of Nov 10, 2022: 57 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $81 M of $81 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Colorado People named in the notice Mary T. Szela · Executive Officer, Director Raj L. Mistry · Executive Officer Sean Murphy · Executive Officer, Director Anil Singhal · Director Diane Parks · Director Gene McGrevin · Director John L. Tullis · Director Kerry Hicks · Director Mats L. Wahlstrom · Director Simone Song · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mary Szela, President. Source: SEC Form D, newest notice filed Nov 10, 2022. Read the notice at the SEC .
equity, options SEC Feb 2017 $13 M No. 4 $10 to $50 million 19
Surefire Medical, Inc.: Raise no. 4, Feb 2017 × Investors in this round 19 investors had bought by the notice of Mar 7, 2017: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $13 M of $15 M offered; $2 M still to sell
Smallest investment taken $1
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Anthony R. Scalese · Executive Officer James E. Chomas · Executive Officer, Director Beverly L. Huss · Director Gene R. McGrevin · Director Ginger L. Graham · Director John R. Tullis · Director Karen J. Cassidy · Director Mats R. Wahlstrom · Director Norman R. Weldon · Director Simone R. Song · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by James E. Chomas, President and CEO. Source: SEC Form D, newest notice filed Mar 7, 2017. Read the notice at the SEC .
equity SEC Jun 2015 $15 M No. 3 $10 to $50 million 54
Surefire Medical, Inc.: Raise no. 3, Jun 2015 × Investors in this round 54 investors had bought by the notice of Nov 5, 2015: 54 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $15 M offered
Smallest investment taken $1
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bob J. Holburn · Executive Officer James E. Chomas · Executive Officer, Director Beverly L. Huss · Director Gene R. McGrevin · Director Ginger L. Graham · Director John R. Tullis · Director Karen J. Cassidy · Director Norman R. Weldon · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by James E. Chomas, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Nov 5, 2015. Read the notice at the SEC .
equity, options SEC Sep 2013 $16 M No. 2 $10 to $50 million 30
Surefire Medical, Inc.: Raise no. 2, Sep 2013 × Investors in this round 30 investors had bought by the notice of Sep 16, 2013: 30 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $16 M of $21 M offered; $5 M still to sell
Smallest investment taken $1
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Aravind R. Arepally · Executive Officer Bob J. Holburn · Executive Officer James Chomas · Executive Officer, Director Karen J. Cassidy · Executive Officer, Director Norman R. Weldon · Executive Officer, Director Gene R. McGrevin · Director Ginger L. Graham · Director Mark L. Lupa · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total Offering Amount: $21,328,000.00 Total Amount Sold: $16,419,987.57 Total Remaining to be Sold: $4,908,012.43”Signed by Bob Holburn, Vice President, CFO. Source: SEC Form D, newest notice filed Sep 16, 2013. Read the notice at the SEC .
equity SEC Apr 2011 $4 M No. 1 $2 to $10 million 42
Surefire Medical, Inc.: Raise no. 1, Apr 2011 × Investors in this round 42 investors had bought by the notice of Apr 26, 2011: 42 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $7 M offered; $3 M still to sell
Smallest investment taken $1
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Aravind R. Arepally · Executive Officer James Chomas · Executive Officer, Director Karen J. Cassidy · Executive Officer, Director Miles J. Gerson · Executive Officer Norman R. Weldon · Executive Officer, Director Ginger L. Graham · Director Mark J. Lupa · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total Offering Amount $6,732,000.00 Total Amount Sold $3,694,524.29 Total Remaining to be Sold $3,037,475.71”Signed by James Chomas, President & Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 26, 2011. Read the notice at the SEC .
equity SEC